Selkirk Pharma Unveils ClinFAST™ to Accelerate Fill/Finish for Clinical Trials
Thursday, February 13, 2025
Selkirk Pharma has introduced ClinFAST™, a new service aimed at accelerating the production of clinical trial supplies.
The fill/finish process is a critical step in drug development, and lengthy wait times can slow progress. Traditional manufacturing slots for small volumes can take between six to twelve months to secure.
ClinFAST™ reduces these delays by running production steps in parallel and using a structured approach to streamline key stages, from compounding to final release.
The initiative addresses a common challenge in the industry, where small-batch projects often face delays due to limited availability in larger contract manufacturing organisations (CMOs).
Selkirk Pharma maintains an inventory of ISO-sized vials, stoppers, filling assemblies, and excipients on-site, which helps reduce sourcing lead times. The service also allows clients to use their own materials if they align with the ClinFAST™ process.
Key benefits of ClinFAST™ include:
- Faster production times: Clinical trial materials can be prepared much quicker than through larger CMOs.
- Batch capacity of up to 10,000 vials: Suitable for liquid-filled vials in early-stage trials.
- Efficient processing: Advanced equipment minimises waste and ensures consistent yields.
- Scalability: Can support companies beyond clinical trials with commercial-scale production.
By offering this dedicated service, Selkirk Pharma aims to help drug developers meet critical clinical trial deadlines while maintaining high-quality standards.
Source: selkirkpharma.com
